Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Rueil Malmaison, France Clinical Trials

A listing of Rueil Malmaison, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (1036) clinical trials

Treatment of Mycobacterium Xenopi Pulmonary Infection

In France, Mycobacterium xenopi is the second non-tuberculous mycobacteria responsible of pulmonary infections. There are few data in the literature regarding its treatment apart from two small randomized trials (42 and 34 patients, respectively) and a French retrospective study (136 patients). So, we decided to conduct a prospective randomized multicenter ...

Phase

2.08 miles

Learn More »

Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis

The primary criteria is the peripheral endothelial function that will be assessed by the measure of flow-mediated dilation (reactive hyperemia-peripheral artery tone index). The pulmonary function will be assessed by the measures of the forced expiratory volume at one second (FEV1), the forced vital capacity (FVC) and the total lung ...

Phase N/A

2.08 miles

Learn More »

Volatile Organic Compounds as Markers of Acute Rejection in Lung Transplant

Prospective single-center study. A single visit, no follow-up. The visit will take place before or within five days from date of transbronchial biopsies (BTB). It will include a noninvasive collection of exhaled breath for VOC analysis. VOC analysis will be conducted using two types of devices: "electronic nose" and mass ...

Phase N/A

2.08 miles

Learn More »

Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke

Intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV t-PA) has been the only proven therapy for acute ischemic stroke (AIS) for almost 20 years. Since December 2014 a new era in acute stroke treatment has begun: randomized controlled studies have consistently shown that endovascular clot retrieval in addition to best ...

Phase N/A

2.08 miles

Learn More »

MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis

Cystic fibrosis (CF) is caused by the cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation and represents one of the most frequent and lethal inherited disease in Caucasian. However, thanks to better treatments that slow down the progression of pulmonary disease, the median life expectancy has reached 41 years and ...

Phase N/A

2.08 miles

Learn More »

Therapeutic Hypothermia in "Expanded Criteria" Brain-dead Donors and Kidney-graft Function

Each year, only one third of patients registered on the waiting list receive a kidney transplant. Numerous paths are being explored with the aim of reversing this shortage. The first is to increase the number of organs by developing harvesting from donors in a state of brain-death (BD) termed "expanded ...

Phase N/A

2.08 miles

Learn More »

Contribution of Learning and Practice of Different Complementary Therapies in Pulmonary Transplant Patients

Patients approaching a lung transplant will face specific infectious, immunological, ventilatory and hemodynamic problems but also to painful, stressful and anxiety-provoking situations. Learning different complementary therapies in the pre-transplant period allows patients to have personal tools to improve their comfort before and after the transplant. These tools can be used ...

Phase N/A

2.08 miles

Learn More »

Medication Reconciliation at Discharge: Impact on Patient's Care

Patient's discharge from hospital is associated with iatrogenic events for 12 to 17% of patients and may lead to further hospitalization. This risk may be linked with discontinuity of care between hospital physicians and Primary Care Physician (PCP) and from discrepancies between patient's current medications and drugs prescribed at discharge. ...

Phase N/A

2.08 miles

Learn More »

Portal Hypertension and Systemic Endothelial Function

Prospective , monocentric study, with four groups of patients: Patients with cystic fibrosis and PHT Cystic fibrosis patients without PHT Patients free from cystic fibrosis with PHT from other causes Healthy controls. One study visit, no follow-up. During the visit the following examinations will be performed: Collection of a blood ...

Phase N/A

2.08 miles

Learn More »

Auriculotherapy and Acupuncture's Treatment for Chemotherapy-induced Nausea and Vomiting (CINV)

The management of chemotherapy-induced nausea and vomiting (CINV) has evolved in recent years and became less frequent. CINV include early (occurring within 24 hours of chemotherapy administration) and delayed (occurring within 4 days after chemotherapy) nausea and vomiting. Preventive treatment, such as Glucocorticoids, 5-HT3 receptor antagonists and NK1 receptor antagonists, ...

Phase N/A

2.08 miles

Learn More »